Stay updated on Trastuzumab Deruxtecan Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Deruxtecan Clinical Trial page.

Latest updates to the Trastuzumab Deruxtecan Clinical Trial page
- Check5 days agoChange DetectedThe page now displays the clinical trial record for the DESTINY-Gastric04 study, including its design, eligibility criteria, locations, outcomes, and data-sharing information, instead of a 403 error.SummaryDifference100%

- Check12 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAn NIH banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology, and the site revision changes from v3.7.1 to v3.7.2. The study page itself remains a 403 error.SummaryDifference1%

- Check40 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error, and the study record content and related sections are no longer accessible, replaced by a standard error page.SummaryDifference17%

- Check62 days agoChange DetectedA new revision label v3.7.0 was added, replacing the previous v3.6.6, indicating an underlying platform update rather than changes to study information.SummaryDifference0.0%

Stay in the know with updates to Trastuzumab Deruxtecan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan Clinical Trial page.